ReviewFEMS microbiology reviews2026
Feeding the invaders: how metabolic imbalance shapes infection and biofilm development.
Review in FEMS microbiology reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Infectious and metabolic disorders have risen sharply and pose a significant threat to human populations worldwide. Despite being deemed unrelated, mounting evidence indicates that metabolic disorders markedly heightened both the likelihood and severity of infectious disease. The mechanism underlying this association is only beginning to be appreciated and involves a complex interaction between altered metabolic state, pathogen virulence mechanisms, and immune effector pathways. Here, we highlight that a dysregulated metabolic environment disrupts homeostasis, creating a nutrient-rich, immunocompromised milieu that promotes bacterial survival and replication in the host. Metabolic dysfunction is also discussed as a factor that promotes bacterial persistence by altering reactive oxygen species production and inducing tissue hypoxia, conditions that favor biofilm growth. We also examine how bacteria directly exploit nutrient surplus in metabolic diseases to boost their virulence programs and biofilm formation. Moreover, given the ever-increasing problem of antibiotic resistance, we discuss how metabolic diseases contribute to this challenge. Collectively, uncovering how metabolic disorders increase chronic or recurrent infections can guide the development of effective treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.